Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiora Pharmaceuticals (KPRX) Prepaid Assets (2016 - 2025)

Kiora Pharmaceuticals (KPRX) has disclosed Prepaid Assets for 9 consecutive years, with $233382.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Prepaid Assets changed N/A year-over-year to $233382.0, compared with a TTM value of $233382.0 through Dec 2023, changed N/A, and an annual FY2023 reading of $233382.0, changed N/A over the prior year.
  • Prepaid Assets was $233382.0 for Q4 2023 at Kiora Pharmaceuticals, down from $488950.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $930345.0 in Q1 2022 and bottomed at $233382.0 in Q4 2023.
  • Average Prepaid Assets over 5 years is $482313.6, with a median of $458810.0 recorded in 2019.
  • The sharpest move saw Prepaid Assets plummeted 47.62% in 2020, then skyrocketed 298.45% in 2022.
  • Year by year, Prepaid Assets stood at $458810.0 in 2019, then dropped by 2.01% to $449569.0 in 2020, then soared by 34.91% to $606520.0 in 2021, then skyrocketed by 53.39% to $930345.0 in 2022, then crashed by 74.91% to $233382.0 in 2023.
  • Business Quant data shows Prepaid Assets for KPRX at $233382.0 in Q4 2023, $488950.0 in Q1 2023, and $930345.0 in Q1 2022.